| Natco Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524816 |
NSE Symbol : NATCOPHARM |
P/E(TTM) : 17.37 |
|
ISIN Demat : INE987B01026 |
Div & Yield% : 0.58 |
EPS(TTM) : 45.47 |
|
Book Value(₹) : 501.20 |
Market Cap(₹Cr) : 15,489.42 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 596.60 | 608.80 | 528.80 | 1,264.30 | 1,192.70 | 1,157.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 596.60 | 608.80 | 528.80 | 1,264.30 | 1,192.70 | 1,157.40 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 48.30 | 72.90 | 55.30 | 93.30 | 59.60 | 62.10 |
| Total Income | 644.90 | 681.70 | 584.10 | 1,357.60 | 1,252.30 | 1,219.50 |
| Total Expenditure | 490.60 | 516.40 | 408.50 | 711.80 | 653.00 | 596.20 |
| PBIDT | 154.30 | 165.30 | 175.60 | 645.80 | 599.30 | 623.30 |
| Interest | 9.60 | 9.70 | 8.30 | 11.70 | 2.60 | 8.80 |
| PBDT | 144.70 | 155.60 | 167.30 | 634.10 | 596.70 | 614.50 |
| Depreciation | 42.70 | 45.60 | 42.10 | 48.10 | 53.80 | 93.70 |
| Tax | 11.00 | 5.60 | 26.20 | 130.60 | 106.00 | 99.40 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 16.40 | -105.20 | -7.90 | -45.50 | -27.20 | -6.70 |
| Reported Profit After Tax | 74.60 | 209.60 | 106.90 | 500.90 | 464.10 | 428.10 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 74.60 | 209.60 | 106.90 | 500.90 | 464.10 | 428.10 |
| EPS (Unit Curr.) | 4.17 | 11.70 | 5.97 | 27.97 | 25.91 | 23.90 |
| EPS (Adj) (Unit Curr.) | 4.14 | 11.61 | 5.92 | 27.74 | 25.70 | 23.71 |
| Calculated EPS (Unit Curr.) | 4.17 | 11.71 | 5.97 | 27.98 | 25.93 | 23.92 |
| Calculated EPS (Adj) (Unit Curr.) | 4.14 | 11.62 | 5.92 | 27.75 | 25.72 | 23.73 |
| Calculated EPS (Ann.) (Unit Curr.) | 16.67 | 46.84 | 23.89 | 111.93 | 103.71 | 95.66 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 16.54 | 46.46 | 23.70 | 111.03 | 102.87 | 94.89 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 75.00 | 75.00 | 100.00 | 0.00 |
| Equity | 35.80 | 35.80 | 35.80 | 35.80 | 35.80 | 35.80 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 25.86 | 27.15 | 33.21 | 51.08 | 50.25 | 53.85 |
| PBDTM(%) | 24.25 | 25.56 | 31.64 | 50.15 | 50.03 | 53.09 |
| PATM(%) | 12.50 | 34.43 | 20.22 | 39.62 | 38.91 | 36.99 |
